Annual Total Debt
$62.08 M
-$1.50 M-2.35%
December 31, 2023
Summary
- As of February 22, 2025, SYRS annual total debt is $62.08 million, with the most recent change of -$1.50 million (-2.35%) on December 31, 2023.
- During the last 3 years, SYRS annual total debt has fallen by -$4.14 million (-6.25%).
- SYRS annual total debt is now -6.25% below its all-time high of $66.21 million, reached on December 31, 2020.
Performance
SYRS Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$60.23 M
-$435.00 K-0.72%
September 30, 2024
Summary
- As of February 22, 2025, SYRS quarterly total debt is $60.23 million, with the most recent change of -$435.00 thousand (-0.72%) on September 30, 2024.
- Over the past year, SYRS quarterly total debt has dropped by -$2.23 million (-3.58%).
- SYRS quarterly total debt is now -9.04% below its all-time high of $66.21 million, reached on December 31, 2020.
Performance
SYRS Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
SYRS Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.4% | -3.6% |
| 3 y3 years | -6.3% | -4.7% |
| 5 y5 years | +10000.0% | -4.7% |
SYRS Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.8% | at low | -7.6% | at low |
| 5 y | 5-year | -6.3% | +139.5% | -9.0% | +132.4% |
| alltime | all time | -6.3% | -100.0% | -9.0% | -100.0% |
Syros Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $60.23 M(-0.7%) |
| Jun 2024 | - | $60.66 M(-1.6%) |
| Mar 2024 | - | $61.67 M(-0.7%) |
| Dec 2023 | $62.08 M(-2.4%) | $62.08 M(-0.6%) |
| Sep 2023 | - | $62.46 M(-0.6%) |
| Jun 2023 | - | $62.83 M(-0.6%) |
| Mar 2023 | - | $63.17 M(-0.6%) |
| Dec 2022 | $63.57 M(-2.5%) | $63.57 M(-0.6%) |
| Sep 2022 | - | $63.97 M(-1.0%) |
| Jun 2022 | - | $64.60 M(-0.5%) |
| Mar 2022 | - | $64.89 M(-0.5%) |
| Dec 2021 | $65.19 M(-1.5%) | $65.19 M(-0.4%) |
| Sep 2021 | - | $65.47 M(-0.4%) |
| Jun 2021 | - | $65.72 M(-0.4%) |
| Mar 2021 | - | $65.97 M(-0.4%) |
| Dec 2020 | $66.21 M(+155.5%) | $66.21 M(+41.6%) |
| Sep 2020 | - | $46.77 M(-0.6%) |
| Jun 2020 | - | $47.06 M(+2.5%) |
| Mar 2020 | - | $45.90 M(+77.1%) |
| Dec 2019 | $25.92 M | $25.92 M(+21.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $21.28 M(+13.1%) |
| Jun 2019 | - | $18.81 M(+538.9%) |
| Mar 2019 | - | $2.94 M(+9396.8%) |
| Dec 2018 | $31.00 K(-41.5%) | $31.00 K(-6.1%) |
| Sep 2018 | - | $33.00 K(-8.3%) |
| Jun 2018 | - | $36.00 K(+300.0%) |
| Mar 2018 | - | $9000.00(-83.0%) |
| Dec 2017 | $53.00 K(-76.0%) | $53.00 K(-44.8%) |
| Sep 2017 | - | $96.00 K(-30.4%) |
| Jun 2017 | - | $138.00 K(-23.3%) |
| Mar 2017 | - | $180.00 K(-18.6%) |
| Dec 2016 | $221.00 K(-34.8%) | $221.00 K(-15.3%) |
| Sep 2016 | - | $261.00 K(-13.3%) |
| Jun 2016 | - | $301.00 K(-6.5%) |
| Mar 2016 | - | $322.00 K(-5.0%) |
| Dec 2015 | $339.00 K(>+9900.0%) | $339.00 K(>+9900.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00 |
| Dec 2014 | $0.00 | - |
FAQ
- What is Syros Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals annual total debt year-on-year change?
- What is Syros Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals quarterly total debt year-on-year change?
What is Syros Pharmaceuticals annual total debt?
The current annual total debt of SYRS is $62.08 M
What is the all time high annual total debt for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high annual total debt is $66.21 M
What is Syros Pharmaceuticals annual total debt year-on-year change?
Over the past year, SYRS annual total debt has changed by -$1.50 M (-2.35%)
What is Syros Pharmaceuticals quarterly total debt?
The current quarterly total debt of SYRS is $60.23 M
What is the all time high quarterly total debt for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high quarterly total debt is $66.21 M
What is Syros Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, SYRS quarterly total debt has changed by -$2.23 M (-3.58%)